Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia
Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2017-02-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/10/2/185 |
id |
doaj-84eef915f84248079459f5ccfa3ecf1d |
---|---|
record_format |
Article |
spelling |
doaj-84eef915f84248079459f5ccfa3ecf1d2020-11-24T21:46:25ZengThe Company of BiologistsDisease Models & Mechanisms1754-84031754-84112017-02-0110218519610.1242/dmm.027086027086Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasiaClaudio Nardiello0Ivana Mižíková1Diogo M. Silva2Jordi Ruiz-Camp3Konstantin Mayer4István Vadász5Susanne Herold6Werner Seeger7Rory E. Morty8 Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), 35392 Giessen, Germany Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), 35392 Giessen, Germany Department of Internal Medicine (Pulmonology), University of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), 35392 Giessen, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, 61231 Bad Nauheim, Germany Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants with BPD. Newborn mouse pups were exposed to a varying fraction of oxygen in the inspired air (FiO2) and a varying window of hyperoxia exposure, after which lung structure was assessed by design-based stereology with systemic uniform random sampling. The efficacy of a candidate therapeutic intervention using parenteral nutrition was evaluated to demonstrate the utility of the standardised BPD model for drug discovery. An FiO2 of 0.85 for the first 14 days of life decreased total alveoli number and concomitantly increased alveolar septal wall thickness, which are two key histopathological characteristics of BPD. A reduction in FiO2 to 0.60 or 0.40 also caused a decrease in the total alveoli number, but the septal wall thickness was not impacted. Neither a decreasing oxygen gradient (from FiO2 0.85 to 0.21 over the first 14 days of life) nor an oscillation in FiO2 (between 0.85 and 0.40 on a 24 h:24 h cycle) had an appreciable impact on lung development. The risk of missing beneficial effects of therapeutic interventions at FiO2 0.85, using parenteral nutrition as an intervention in the model, was also noted, highlighting the utility of lower FiO2 in selected studies, and underscoring the need to tailor the model employed to the experimental intervention. Thus, a state-of-the-art BPD animal model that recapitulates the two histopathological hallmark perturbations to lung architecture associated with BPD is described. The model presented here, where injurious stimuli have been systematically evaluated, provides a most promising approach for the development of new strategies to drive postnatal lung maturation in affected infants.http://dmm.biologists.org/content/10/2/185BPDHyperoxiaAlveolarisationStructureAnimal model |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Claudio Nardiello Ivana Mižíková Diogo M. Silva Jordi Ruiz-Camp Konstantin Mayer István Vadász Susanne Herold Werner Seeger Rory E. Morty |
spellingShingle |
Claudio Nardiello Ivana Mižíková Diogo M. Silva Jordi Ruiz-Camp Konstantin Mayer István Vadász Susanne Herold Werner Seeger Rory E. Morty Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia Disease Models & Mechanisms BPD Hyperoxia Alveolarisation Structure Animal model |
author_facet |
Claudio Nardiello Ivana Mižíková Diogo M. Silva Jordi Ruiz-Camp Konstantin Mayer István Vadász Susanne Herold Werner Seeger Rory E. Morty |
author_sort |
Claudio Nardiello |
title |
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia |
title_short |
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia |
title_full |
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia |
title_fullStr |
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia |
title_full_unstemmed |
Standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia |
title_sort |
standardisation of oxygen exposure in the development of mouse models for bronchopulmonary dysplasia |
publisher |
The Company of Biologists |
series |
Disease Models & Mechanisms |
issn |
1754-8403 1754-8411 |
publishDate |
2017-02-01 |
description |
Progress in developing new therapies for bronchopulmonary dysplasia (BPD) is sometimes complicated by the lack of a standardised animal model. Our objective was to develop a robust hyperoxia-based mouse model of BPD that recapitulated the pathological perturbations to lung structure noted in infants with BPD. Newborn mouse pups were exposed to a varying fraction of oxygen in the inspired air (FiO2) and a varying window of hyperoxia exposure, after which lung structure was assessed by design-based stereology with systemic uniform random sampling. The efficacy of a candidate therapeutic intervention using parenteral nutrition was evaluated to demonstrate the utility of the standardised BPD model for drug discovery. An FiO2 of 0.85 for the first 14 days of life decreased total alveoli number and concomitantly increased alveolar septal wall thickness, which are two key histopathological characteristics of BPD. A reduction in FiO2 to 0.60 or 0.40 also caused a decrease in the total alveoli number, but the septal wall thickness was not impacted. Neither a decreasing oxygen gradient (from FiO2 0.85 to 0.21 over the first 14 days of life) nor an oscillation in FiO2 (between 0.85 and 0.40 on a 24 h:24 h cycle) had an appreciable impact on lung development. The risk of missing beneficial effects of therapeutic interventions at FiO2 0.85, using parenteral nutrition as an intervention in the model, was also noted, highlighting the utility of lower FiO2 in selected studies, and underscoring the need to tailor the model employed to the experimental intervention. Thus, a state-of-the-art BPD animal model that recapitulates the two histopathological hallmark perturbations to lung architecture associated with BPD is described. The model presented here, where injurious stimuli have been systematically evaluated, provides a most promising approach for the development of new strategies to drive postnatal lung maturation in affected infants. |
topic |
BPD Hyperoxia Alveolarisation Structure Animal model |
url |
http://dmm.biologists.org/content/10/2/185 |
work_keys_str_mv |
AT claudionardiello standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT ivanamizikova standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT diogomsilva standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT jordiruizcamp standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT konstantinmayer standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT istvanvadasz standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT susanneherold standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT wernerseeger standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia AT roryemorty standardisationofoxygenexposureinthedevelopmentofmousemodelsforbronchopulmonarydysplasia |
_version_ |
1725902290358894592 |